Novartis India Limited

NSE:NOVARTIND.NS

674 (INR) • At close October 25, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q2
Revenue 811.7845.4787.6906761.3801.71,015.21,209.2860.2989.61,044.8981.1835.5937.7958.3924.66681,174.61,177.81,093.1700.41,356.21,065.81,3811,253.21,5611,676.51,148.21,4551,643.71,750.61,713.11,672.71,925.72,244.32,240.52,076.42,2222,347.92,087.52,005.72,246.42,139.22,2312,128.52,335.42,374.32,195.42,028.62,223.22,189.8
Cost of Revenue 621.4454.9447.2527.4460.6471.5510.3574.5527.4437.5450.6399.2354.3421.4367.2353.4272.4472.6594.2514.4351.4574.6497.7597.4570.8637.7714.1532.5712.5708.1825.7814.9731.2884.4931.1949.9710.8950.6983.2884.58181,066.51,040.91,005.3876.5961.61,018.3860.1801.5826.5775.7
Gross Profit 190.3390.5340.4378.6300.7330.2504.9634.7332.8552.1594.2581.9481.2516.3591.1571.2395.6702583.6578.7349781.6568.1783.6682.4923.3962.4615.7742.5935.6924.9898.2941.51,041.31,313.21,290.61,365.61,271.41,364.71,2031,187.71,179.91,098.31,225.71,2521,373.81,3561,335.31,227.11,396.71,414.1
Gross Profit Ratio 0.2340.4620.4320.4180.3950.4120.4970.5250.3870.5580.5690.5930.5760.5510.6170.6180.5920.5980.4960.5290.4980.5760.5330.5670.5450.5910.5740.5360.510.5690.5280.5240.5630.5410.5850.5760.6580.5720.5810.5760.5920.5250.5130.5490.5880.5880.5710.6080.6050.6280.646
Reseach & Development Expenses 000000000000000000000000000000000000000000000000000
General & Administrative Expenses 000086.70000000000000000000000000000000000000000000000
Selling & Marketing Expenses 0000610000000000000000000000000000000000000000000000
SG&A 79.6129.8117.661.8147.7163.9226.6225.10000000000000000000000000000000000000000000
Other Expenses 104.2219.6168.8124.7163.783.668.6265.2-12560.463.864.6-122.937.75669.6-280.173100.1108.9-648.2114.7310.8222.81,096666251226.8148.1723.2585.9600.61,261834.21,005.81,084.41,870.61,226.51,150994.51,743.4963.6959.11,208.31,763952.47721,150.31,223.3835.5762.3
Operating Expenses 79.6193.7177.8221224.6266.8355.5329.7272.3514550.1532.6355.2575.9520559.9300.9644.6642.9662.9119.5656.1750.5825.2907.8666809.5743.7814.9723.2585.9600.61,261834.21,005.81,084.41,870.61,226.51,150994.51,743.4963.6959.11,208.31,763952.47721,150.31,223.3835.5762.3
Operating Income 110.7416.4331.4157.6239.814721830543.138.144.149.3126-59.671.111.394.757.4-59.3-84.2229.5125.5-182.4-41.6-225.4257.3152.9-128-72.4212.4339297.6-319.5207.1307.4206.2-50544.9214.7208.5-555.7216.3139.217.4-511421.45841853.8561.2651.8
Operating Income Ratio 0.1360.4930.4210.1740.3150.1830.2150.2520.050.0390.0420.050.151-0.0640.0740.0120.1420.049-0.05-0.0770.3280.093-0.171-0.03-0.180.1650.091-0.111-0.050.1290.1940.174-0.1910.1080.1370.092-0.2430.020.0910.1-0.2770.0960.0650.008-0.240.180.2460.0840.0020.2520.298
Total Other Income Expenses Net 102.6-3.3-7.1120.1-6.7-4.6-4.9260.2-356.645.848.849.29366.439.452.840.856.483.397.394.3114.4310.5207.51,044.6-3.2250.5226.5144-2.5-0.4-0.42,415-0.5-0.5-0.5957.1-0.5-0.6-0.5878.3-0.7-0.6204.8808.6-4.6-0.4211.2473.2-0.6-1.8
Income Before Tax 213.3413.1324.3277.7233.1142.4213.1565.2-313.583.992.998.52196.8110.564.1135.5113.82413.1323.8239.9128.1165.9819.2254.1403.498.571.6209.9338.6297.22,095.5206.6306.9205.7452.144.4214.1208322.6215.6138.6222.2297.6416.8583.6396.2477560.6650
Income Before Tax Ratio 0.2630.4890.4120.3070.3060.1780.210.467-0.3640.0850.0890.10.2620.0070.1150.0690.2030.0970.020.0120.4620.1770.120.120.6540.1630.2410.0860.0490.1280.1930.1731.2530.1070.1370.0920.2180.020.0910.10.1610.0960.0650.10.140.1780.2460.180.2350.2520.297
Income Tax Expense 66.5147.487.575.1-17.166.329.641.4-79.820.422.735.712213.935.320.267.736.576.25.2128.5111.234.465.9554.566.7142.228.242.579.6116.5106.5500.281.2115.770.5-22.3973.764.983.863.3-316.983.553.5126.8190.2126.4147.8177.1218.2
Net Income 146.8265.7236.8202.6250.276.1183.5523.8-233.763.570.262.897-7.175.243.967.877.3-52.27.9195.3128.793.7100264.7187.4261.270.329.1130.3222.1190.7215.3598.11,038.2134.5519.4-11.8140.4143.1238.8152.3455.5138.7244.1290393.4269.8329.2383.5431.8
Net Income Ratio 0.1810.3140.3010.2240.3290.0950.1810.433-0.2720.0640.0670.0640.116-0.0080.0780.0470.1010.066-0.0440.0070.2790.0950.0880.0720.2110.120.1560.0610.020.0790.1270.1110.1290.3110.4630.060.25-0.0050.060.0690.1190.0680.2130.0620.1150.1240.1660.1230.1620.1720.197
EPS 5.9510.769.598.2110.133.087.4321.21-9.472.572.842.553.96-0.293.051.782.753.13-2.110.327.915.213.84.059.66.669.282.51.034.777.035.976.7418.7232.484.2116.25-0.374.394.487.474.7714.254.347.649.0712.318.4410.311.9913.51
EPS Diluted 5.9510.769.598.2110.133.087.4321.21-9.462.572.842.553.96-0.293.051.782.753.13-2.110.327.915.213.84.059.66.669.282.51.034.777.035.976.7418.7232.484.2116.25-0.374.394.487.474.7714.254.347.649.0712.318.4410.311.9913.51
EBITDA 112.1419337.9297.9260.6160231.8583.2-297.1126134.7143275.48.9158.1111.5189.5163.172.256.9332.9249.7135187.8877262.7410.3105.888.9220.4346.1305-308.4215.1316.4214.8462.954.9223.6217.3-547.2225.7148.5-178.8-500.9432591.6-19.4486.8568.8659
EBITDA Ratio 0.1380.4960.4290.3290.3420.20.2280.482-0.3450.1270.1290.1460.330.0090.1650.1210.2840.1390.0610.0520.4750.1840.1270.1360.70.1680.2450.0920.0610.1340.1980.178-0.1840.1120.1410.0960.2230.0250.0950.104-0.2730.10.069-0.08-0.2350.1850.249-0.0090.240.2560.301